Ambit Biosciences Company
![](/files/companies/Ambit%20Biosciences.jpg)
Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.
Headquarters:
San Diego, California, United States
Total Funding:
215727869 USD
Founded Date:
2000
Employee Number:
51-100
Last Funding Type:
Venture - Series Unknown
Investors Number:
15
Last Funding Date:
2012-11-06
Technology:
Immunotherapy
Funding Status:
M&A
Estimated Revenue:
$10M to $50M
Industry:
PharmTech